Literature DB >> 15736119

Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia.

Werner Kern1, Achim Peters, Jan Born, Horst L Fehm, Bernd Schultes.   

Abstract

Hyperinsulinemia has been shown to induce activation of the sympathetic nervous system and vasodilatation. Whether these effects result in changes in blood pressure (BP) is discussed controversially. We measured BP and plasma catecholamine levels in 30 healthy men during a 60-minute baseline phase and 360-minute period of insulin infusion. In a double-blind, between-subject comparison, insulin was infused at a low rate (1.5 mU insulin/kg per minute) in one half of the subjects and at a high rate (15 mU/kg per minute) in the other half. Throughout the experiments, blood glucose levels were held constantly within the normal range by a simultaneous infusion of glucose. Serum insulin levels increased to a plateau of 543 +/- 34 pmol/L during low rate and to 24,029 +/- 1,595 pmol/L during high rate of insulin infusion. Compared with baseline, insulin infusion of either rate significantly increased systolic BP, BP amplitude, and heart rate (all P < .05). In comparison with the low rate of insulin infusion, the high rate provoked a more pronounced increase in heart rate (P < .02) and systolic BP (P < .05) but tended to decrease diastolic BP (P < .08) summing up to a distinctly more increased BP amplitude (P < .05). Plasma norepinephrine as well as epinephrine levels did not significantly change during the low-rate insulin infusion but significantly increased during high-rate insulin infusion (both P < .05). By showing a dose-dependent increasing influence of insulin on systolic BP and circulating catecholamine levels, the present study provides experimental evidence for the notion that hyperinsulinemia contributes to the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736119     DOI: 10.1016/j.metabol.2004.10.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

Review 1.  Use of metformin in diseases of aging.

Authors:  John M Miles; Andrew D Rule; Barry A Borlaug
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

2.  QT Interval Shortening After Bariatric Surgery Depends on the Applied Heart Rate Correction Equation.

Authors:  Erik K Grasser; Barbara Ernst; Martin Thurnheer; Bernd Schultes
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

3.  Subfornical organ insulin receptors tonically modulate cardiovascular and metabolic function.

Authors:  Jin Kwon Jeong; Julie A Horwath; Hayk Simonyan; Katherine A Blackmore; Scott D Butler; Colin N Young
Journal:  Physiol Genomics       Date:  2019-06-07       Impact factor: 4.297

4.  Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.

Authors:  Martin K Rutter; Lisa M Sullivan; Caroline S Fox; Peter W F Wilson; David M Nathan; Ramachandran S Vasan; Ralph B D'Agostino; James B Meigs
Journal:  Metab Syndr Relat Disord       Date:  2014-07-09       Impact factor: 1.894

5.  Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Authors:  James T Thackeray; Rob S Beanlands; Jean N Dasilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-20

Review 6.  Brain insulin signaling and Alzheimer's disease: current evidence and future directions.

Authors:  Helgi B Schiöth; Suzanne Craft; Samantha J Brooks; William H Frey; Christian Benedict
Journal:  Mol Neurobiol       Date:  2011-12-29       Impact factor: 5.590

7.  Prevalence and control of hypertension in iraqi diabetic patients: a prospective cohort study.

Authors:  Abbas Ali Mansour
Journal:  Open Cardiovasc Med J       Date:  2012-05-18

Review 8.  Hypertension and the cardiometabolic syndrome.

Authors:  Camila Manrique; Guido Lastra; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

Review 9.  Intranasal treatment of central nervous system dysfunction in humans.

Authors:  Colin D Chapman; William H Frey; Suzanne Craft; Lusine Danielyan; Manfred Hallschmid; Helgi B Schiöth; Christian Benedict
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

10.  Resting sympathetic activity is associated with the sympathetically mediated component of energy expenditure following a meal.

Authors:  Jacqueline K Limberg; Katherine R Malterer; Luke J Matzek; James A Levine; Nisha Charkoudian; John M Miles; Michael J Joyner; Timothy B Curry
Journal:  Physiol Rep       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.